FDA Advisers Give Thumbs Up to Guardant Health’s Blood Test for Colorectal Cancer
In a scene worthy of a medical drama, advisers to the U.S. Food and Drug Administration cast a crucial vote on Thursday, leaning 7-to-2 in favor of Guardant Health’s (NASDAQ:GH) blood test, Shield, for detecting colorectal cancer (CRC). The FDA is expected to...
Justice Department to Sue Live Nation, Eyeing Ticketmaster Breakup After Taylor Swift Ticket Fiasco
The U.S. Department of Justice and a coalition of states are turning up the heat on Live Nation Entertainment (NYSE:LYV), planning to sue and possibly break up the concert giant, Bloomberg News revealed on Wednesday. This lawsuit is the latest salvo in an antitrust...
Viasat’s Revenue Forecast Misses the Mark, Shares Plunge Over 11%
Viasat’s crystal ball was a bit cloudy on Tuesday, as the company predicted annual revenue below Wall Street’s expectations due to a slowdown in its satellite services business, causing its shares to nosedive more than 11% after hours. Anticipating a dip...Tech Rally Pauses Ahead of Nvidia Earnings, Fed Minutes in Focus
Tech Rally Pauses Ahead of Nvidia Earnings, Fed Minutes in Focus U.S. stock index futures barely budged in the Monday evening shuffle, as Wall Street’s enthusiasm for tech stocks took a breather. The tech-fueled rally that catapulted the Nasdaq to record highs...
